Citrine Global Corp.

Equities

CTGL

US17737V1052

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets 14:37:11 07/05/2024 BST			5-day change	1st Jan Change
0.01 ^USD	0.00%		0.00%	-50.00%

02-23	Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board	CI
02-09	Citrine Global Corp. announced that it has received $0.055 million in funding	CI

Citrine Global Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 16, 2021 at 09:42 pm

Citrine Global Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 204,235 compared to USD 1.032 million a year ago. Net loss was USD 858,692 compared to USD 1.096 million a year ago. For the half year, sales was USD 0 compared to USD 11,372 a year ago. Operating loss was USD 2.178 million compared to USD 1.724 million a year ago. Net loss was USD 2.959 million compared to USD 1.785 million a year ago.

Latest news about Citrine Global Corp.

Citrine Global Corp. Announces Resignation of Mr. Doron Birger from the Board	02-23	CI
Citrine Global Corp. announced that it has received $0.055 million in funding	02-08	CI
Citrine Global Corp. acquired 19% stake in iBOT Israel-Botanicals LTD.	12-30	CI
Citrine Global Corp. signed a binding agreement to acquire 19% stake in iBOT Israel-Botanicals LTD for NIS 5.23 million.	11-20	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/08/23	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	22/03/23	CI
Citrine Global Corp. acquired 18.33% of stake in Total Access Communication Public Company Limited from Thai Telco Holdings Limited.	14/02/23	CI
Citrine Global Corp. Announces Management Changes	18/01/23	CI
Citrine Global Corp. completed the acquisition of 10% stake in MyPlant Bio Ltd from PurPlant Inc and Cannasoul Analytics Ltd.	29/12/22	CI
Citrine Global Corp. entered into a Memorandum of Understanding to acquire 10% stake in MyPlant Bio Ltd from PurPlant Inc and Cannasoul Analytics Ltd for $0.44 million.	11/12/22	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22	CI
Citrine Global Corp. Announces Executive Changes	25/10/22	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	08/04/22	CI
Citrine Global Corp. and Intelicanna Ltd Enters into Binding Memorandum of Understanding	20/01/22	CI
Citrine Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Citrine Global Subsidiary Files in the U.S. Patent & Trademark Office A Provisional Patent Application for Pharmaceutical Compositions and Methods for the Treatment of Side Effects Associated with the Use of Cannabis & Related Products	02/11/21	CI
Citrine Global Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21	CI
Citrine Global Subsidiary Enters into Manufacturing Agreement for the Green Botanicals Product Line	10/08/21	CI
Citrine Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21	CI
Citrine Global Corp. Appoints David Kretzmer as Member of the Board of Directors	30/04/21	CI
Citrine Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	15/04/21	CI

Chart Citrine Global Corp.

Duration

Period

More charts

Company Profile

Citrine Global Corp, formerly knows as Techcare Corp., is an Israeli-based company. The Company is engaged is an operational, asset and real estate finance, and consultancy in value creation and implementation strategy for technology companies. Citrine Global focuses on these industries such as health, wellness, food tech and medical cannabis.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CITRINE GLOBAL CORP.	-50.00%	10.44M
ABBOTT LABORATORIES	-5.23%	181B
MEDTRONIC PLC	+1.92%	112B
BECTON, DICKINSON AND COMPANY	-3.76%	67.92B
DEXCOM, INC.	+4.32%	50.1B
CENCORA, INC.	+8.72%	44.27B
HOYA CORPORATION	+9.39%	40.41B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.22%	31.95B
WEST PHARMACEUTICAL SERVICES, INC.	-0.68%	25.82B
TERUMO CORPORATION	+17.27%	25.29B

Other Medical Equipment, Supplies & Distribution